AG
OCUL icon

Algert Global’s Ocular Therapeutix OCUL Stock Holding History

Algert Global’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.57M Buy
538,939
+411,529
+323% +$3.92M 0.07% 467
2025
Q4 		$1.55M Buy
+127,410
New +$1.55M 0.02% 767
2025
Q2 		– Sell
-29,020
Closed -$213K – 1299
2025
Q1 		$213K Buy
+29,020
New +$223K 0.01% 1075
2024
Q3 		– Sell
-10,114
Closed -$69K – 1461
2024
Q2 		$69K Buy
+10,114
New +$62.4K ﹤0.01% 1430
2023
Q4 		– Sell
-25,480
Closed -$80K – 1221
2023
Q3 		$80K Sell
25,480
-23,750
-48% -$97.2K ﹤0.01% 1046
2023
Q2 		$254K Buy
+49,230
New +$293K 0.01% 940
2022
Q4 		– Sell
-73,590
Closed -$305K – 1235
2022
Q3 		$305K Buy
73,590
+5,310
+8% +$26.7K 0.02% 945
2022
Q2 		$274K Buy
68,280
+56,423
+476% +$213K 0.02% 942
2022
Q1 		$59K Buy
+11,857
New +$65.7K ﹤0.01% 1134
2021
Q4 		– Sell
-10,100
Closed -$101K – 1066
2021
Q3 		$101K Buy
+10,100
New +$113K 0.01% 966

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return